Hemagglutinin Stalk Antibody Responses Following Trivalent Inactivated Influenza Vaccine Immunization of Pregnant Women and Association With Protection From Influenza Virus Illness

Abstract Background The conserved, immuno-subdominant influenza virus hemagglutinin (HA) stalk region is a potential universal group-specific influenza virus vaccine epitope. We analyzed antibody responses to H1 hemagglutinin stalk domain (H1/stalk) following trivalent influenza inactivated vaccine...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical infectious diseases 2020-08, Vol.71 (4), p.1072-1079
Main Authors:	Dhar, Nisha, Kwatra, Gaurav, Nunes, Marta C, Cutland, Clare, Izu, Alane, Nachbagauer, Raffael, Krammer, Florian, Madhi, Shabir A
Format:	Article
Language:	eng
Subjects:	and Commentaries Antibodies, Viral Antibody Formation Female Hemagglutinin Glycoproteins, Influenza Virus Hemagglutinins HIV Infections Humans Influenza A Virus, H1N1 Subtype Influenza Vaccines Influenza, Human - prevention & control Pregnancy Pregnant Women
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Abstract Background The conserved, immuno-subdominant influenza virus hemagglutinin (HA) stalk region is a potential universal group-specific influenza virus vaccine epitope. We analyzed antibody responses to H1 hemagglutinin stalk domain (H1/stalk) following trivalent influenza inactivated vaccine (IIV3) immunization in pregnant women, and association with protection against influenza virus illness. Methods One hundred forty-five human immunodeficiency virus (HIV)–uninfected pregnant women (68 IIV3 and 77 placebo recipients) and 140 pregnant women with HIV infection (72 IIV3 and 68 placebo recipients) were independently randomized in placebo-controlled efficacy trials of IIV3. Plasma samples were tested for H1/stalk immunoglobulin G (IgG) and hemagglutination inhibition (HAI) antibodies prevaccination and 1 month postvaccination. Women had weekly surveillance for influenza illness, confirmed by polymerase chain reaction. Results Increases in H1/stalk IgG (and HAI) antibody levels were elicited post-IIV3, with responses being higher in HIV-uninfected women than in women living with HIV. Among HIV-uninfected vaccinees, there was no correlation (postvaccination) between H1/stalk and HAI antibody responses, whereas a strong correlation was observed in vaccinees with HIV. The H1/stalk IgG concentration was lower among women developing A/H1N1 illness (85.3 arbitrary units [AU]/mL) than those without A/H1N1 illness (219.6 AU/mL; P = .001). H1/stalk IgG concentration ≥215 AU/mL was associated with 90% lower odds (odds ratio, 0.09; P = .005) of A/H1N1 illness. Also, H1/stalk IgG was significantly lower among women with influenza B illness (93.9 AU/mL) than among their counterparts (215.5 AU/mL) (P = .04); however, no association was observed after adjusting for HAI titers. Conclusions H1/stalk IgG concentration was associated with lower odds for A/H1N1 influenza virus illness, indicating its potential as an epitope for a universal vaccine against group 1 influenza virus. This study showed an association of H1 hemagglutinin stalk-specific immunoglobulin G in broader protection from influenza virus infections in pregnant women in a placebo-controlled trial of an inactivated influenza vaccine trial. The findings have implications on designing more-effective influenza vaccine candidates.
ISSN:	1058-4838 1537-6591